Answers are grounded in this paper and cite their sources.
Background SARS-CoV-2 and Plasmodium falciparum coexist in Africa, raising questions about potential immunological interactions between both pathogens, which could have impacted the COVID-19 pandemic in the continent. However, few studies have assessed the relationship between malaria exposure and SARS-CoV-2 infection, symptomatology, and potential antibody cross-reactivity. Methods We conducted a sero-epidemiological study using plasma samples collected in Mozambique and Spain between 2001 and 2022. IgG, IgM, and IgA responses to spike (S) and nucleocapsid (N) SARS-CoV-2 and blood stage P. falciparum antigens were measured using a multiplex assay to evaluate potential cross-reactivity between antibodies. COVID-19 pre-pandemic samples from Mozambique ( n = 175) and Spain ( n = 35) were used to assess baseline IgG cross-reactivity. Post-pandemic samples from 2,576 individuals in Manhiça, Mozambique (2021–2022), were analyzed to examine associations between malaria exposure, quantified by a composite malaria IgG score, and SARS-CoV-2 infection, seropositivity and COVID-19 symptomatology. Statistical tests included t-tests, Spearman correlations, and unadjusted logistic regressions. Results The quantitative suspension array antibody assay to assess SARS-CoV-2 seropositivity achieved high sensitivity (IgG: 85%; IgA: 75%) and specificity (> 93%), with best performance for S and receptor-binding domain (RBD) antigens. Pre-pandemic African samples showed significantly higher anti-SARS-CoV-2 IgG reactivity than the European ones ( p < 0.0001). In pre-pandemic samples, moderate correlations were observed between anti– P. falciparum and anti–SARS-CoV-2 IgG (e.g., RBD vs. EBA-175, r = 0.41, p < 0.001). In post-pandemic samples, correlations weakened with rising SARS-CoV-2 seroprevalence. Prior exposure to malaria was not associated with SARS-CoV-2 infection, SARS-CoV-2 seropositivity or COVID-19 symptomatology. Conclusions Our findings demonstrate evidence of serological cross-reactivity between antibodies against P. falciparum and SARS-CoV-2 in pre-pandemic African samples. These results highlight the importance of sero-surveillance approaches that account for co-endemic pathogens to better inform public health strategies in these co-endemic regions. Clinical Trial Not applicable.
No takes yet. Share an insight, caveat, or question.
Escoda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: